Other clinical trials in clients with non-Hodgkin's lymphoma [24] and individuals with advanced malignancy [14] have proven also that zosuquidar didn't considerably affect the pharmacokinetics of doxorubicin and had average effects around the pharmacokinetics of vincristine. These medical trials approved that zosuquidar could securely administrated with daunorubicin, doxorubicin as well https://chandrak887cny4.topbloghub.com/profile